Literature DB >> 10873510

Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium.

K S Woo1, L C Armiger, H D White, R M Norris.   

Abstract

The aim of this study was to evaluate whether streptokinase (SK) may produce beneficial effects at the level of microvascular circulation in addition to coronary recanalization. Twenty mongrel dogs weighing 28.4 +/- 4.6 kg were randomized to receive SK (16,000-72,000 U/kg) or 20 ml saline (control) in an open-chest anterior descending artery occlusion (3 h) and reperfusion (2 h) model. Myocardial blood flow was measured by the radioactive microsphere technique and the state of microvascular circulation (red blood cell containing capillary counts and tissue red blood cell content) was evaluated in the infarcted subendocardial zone using computerized image analysis. The percentage (mean +/- SE) of cell-containing vessels normalized to nonischemic control areas was 166.5 +/- 7.5 in SK-treated infarcts while in untreated control infarcts it was more variable (130.0 +/- 15.6%) (2P > 0.1). The red blood cell content of infarcts treated with 2.0 megaunits SK was 3.9 +/- 0.6% compared with 6.7 +/- 0.9% in untreated control infarcts (2P = 0.029). Plasma viscosity was slightly reduced in SK-treated dogs (2P = 0.05), but no significant changes in blood fibrinogen, hemoglobin, blood flow, and high energy phosphate levels between control and SK-treated infarcts were observed. SK reduces congestion and results in more even reperfusion of the microvasculature in severely ischemic myocardium to which blood flow has been restored. This effect may be beneficial in the salvage and healing of clinical infarctions. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873510     DOI: 10.1006/mvre.2000.2236

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  4 in total

Review 1.  Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

Authors:  Vijayalakshmi Kunadian; Cafer Zorkun; Scott P Williams; Leah H Biller; Alexandra M Palmer; Katherine J Ogando; Michelle E Lew; Navin Nethala; William J Gibson; Susan J Marble; Jacqueline L Buros; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-09-26       Impact factor: 2.300

2.  "Rescue administration" of intracoronary thrombolytic therapy for drug-eluting stent thrombosis.

Authors:  C Y Karabay; G Kocabay; A Kalayci; O Tasar; C Kirma
Journal:  Herz       Date:  2013-07-24       Impact factor: 1.443

3.  Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man.

Authors:  Christian M Pedersen; Gareth Barnes; Michael R Schmidt; Hans Erik Bøtker; Rajesh K Kharbanda; David E Newby; Nicholas L Cruden
Journal:  Eur Heart J       Date:  2011-10-11       Impact factor: 29.983

Review 4.  Tissue conservation for transplantation.

Authors:  Nicco Krezdorn; Sotirios Tasigiorgos; Luccie Wo; Marvee Turk; Rachel Lopdrup; Harriet Kiwanuka; Thet-Su Win; Ericka Bueno; Bohdan Pomahac
Journal:  Innov Surg Sci       Date:  2017-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.